TheProfitWatch

NRXP - NRX Pharmaceuticals, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
2.05 0.1 (4.63%) --- 0.02 (0.7%) 0.02 (1.18%) 0.0 (0.0%) 0.15 (7.25%) 0.04 (2.2%) 0.03 (1.71%)

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.98
Diluted EPS:
Basic P/E:
-2.1888
Diluted P/E:
RSI(14) 1m:
100.0
VWAP:
2.13
RVol:

Events

Period Kind Movement Occurred At

Related News